The Australian equity market continues to slide in afternoon trade, as investors take money off the table after the strong run recently.
Black Rock has been holding meetings with potential European and Asian offtake partners, with its global marketing activities are directed at securing long term offtake supply agreements from Mahenge.
Lithium drilling news flow will increase rapidly in coming months. Drilling is on track to be underway in September 2016 at both Raleigh and Pioneer Dome.
Hazer is commercialising a process for manufacturing hydrogen gas and high-purity graphite from natural gas and iron ore.
Find out more from MD Geoff Pocock presents at Proactive's Spotlight CEO Sessions in Sydney, 3 August. Register today!
Funds will enable the company to focus on the current drill program testing deep gravity targets at the 90% owned Red Bore project located in Western Australia.
Prospect Resources Ltd has assayed up to 4.37% lithium at Arcadia in Zimbabwe. The company has also received commitments to raise an additional $2 million, increasing the recent placement raising to $16 million.
The successful drilling at Cathedrals and Stricklands has significantly increased the nickel-copper sulphide system at Mt Alexander. This could be substantially expanded by the imminent drilling at the Investigators Prospect.
The offer is priced at $0.02, with Alara shares last trading at a premium of $0.024. Rights trading is still underway, and closes on Tuesday 26th July 2016. The issue is fully underwritten by CPS Capital Group.
Real Estate Investar Group is a provider of online tools for property investors in Australia and New Zealand.
Find out more when MD Clint Greaves presents at Proactive's Spotlight CEO Session in Sydney, 3 August. Register today!
U.S. stocks snapped a nine-day winning streak overnight, after the latest clutch of earnings reports rang in.
The ASX SPI 200 is off 0.6% to 5452.
The gold bars are estimated to be worth $2 million at current gold prices representing the highest single gold pour to date.
Anatara is developing therapeutics for gastrointestinal diseases in pigs and humans.
Find out the next steps when CEO Dr Paul Schober presents at Proactive's Spotlight CEO Sessions in Sydney, 3 August. Register today!